GKB Ophthalmics P/B Ratio
GKB Ophthalmics (GKB) P/B ratio is 0.61 (Low), book value per share ₹106.00 vs Healthcare average P/B of -0.34 — Low - Trading below book value, may indicate undervaluation. Compare with GKB Ophthalmics valuation methods to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GKB P/B Ratio — Valuation Insights & Book Value Analysis
GKB Ophthalmics price-to-book ratio interpretation, valuation status and historical context — current P/B 0.61 (Low). For live price, earnings yield and the full fundamental profile, see GKB share price screener.
- Stock appears undervalued with PB of 0.61, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of -0.34
GKB Ophthalmics P/B Ratio Historical Trend
GKB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View GKB yearly price range for the annual high/low range and current price position.
GKB Historical P/B Ratio — Book Value Per Share & Year-End Price
GKB Ophthalmics annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.6 | ₹106.0 | ₹64.05 | ₹53 | Low |
| 2025 | 0.46 | ₹112.0 | ₹51.24 | ₹56 | Low |
| 2024 | 0.77 | ₹128.0 | ₹98.75 | ₹64 | Low |
| 2023 | 0.75 | ₹134.0 | ₹100.06 | ₹67 | Low |
| 2022 | 0.83 | ₹134.0 | ₹110.70 | ₹67 | Low |
GKB vs Healthcare Peers — P/B Ratio Comparison
GKB Ophthalmics P/B 0.61 vs Healthcare average -0.34, median 0.62 — range -18.41–1.12.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |